Study of Anlotinib in Patients With Medullary Thyroid Carcinoma(ALTER01031)

Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing

Jilin Cancer Hospital, Changchun

20th Floor, Block C, Lake Road, Hexi District, Tianjin Medical University Cancer Institute and Hospital ., Tianjin

Zhejiang Cancer Hospital, Hangzhou

West China Hospital Of Sichuan University, Chongqing

Chongqing Cancer Hospital, Chongqing

Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan

Beijing Tongren Hospital, Beijing

Peking Union Medical College Hospital, Beijing

Fujian Cancer Hospital, Fuzhou

Gansu Province Tumor Hospital, Lanzhou

Sun Yat-Sen University Cancer Center, Guozhou

Harbin medical university affiliated tumor hospital, Harbin

Henan Province Tumor Hospital, Zhengzhou

Hunan Province Tumor Hospital, Changsha

Jiangsu province tumor hospital, Nanjing

Liaoning Province Tumor Hospital, Shenyang

Cancer Hospital of Fudan University, Shanghai

The First Affiliated Hospital of Kunming Medical University, Kunming